Home » Topics » BioWorld Science

BioWorld Science
RSS

WVE-004 shows promise for treating C9orf72-associated neurologic disorders

April 27, 2022

CIDRAP receives funding to create coronavirus vaccines R&D roadmap

April 27, 2022

PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403

April 27, 2022

Virpax reports preclinical PK results for VRP-324 for management of seizures

April 27, 2022

Algernon's NP-251 shown to reduce fibrosis in preclinical NASH study

April 27, 2022

NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers

April 27, 2022

ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace

April 27, 2022

AstraZeneca presents new PROTACs for cancer

April 27, 2022

Cullgen identifies new PROTACs

April 27, 2022

Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors

April 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.